Peakhill's Credit Facility Gets Costlier at Low Utilization

Peakhill has secured a funding source that can change its growth rate, but C$350 million of available credit is not revenue. Based on the rates detailed at signing, draw costs range from 3.8% to 5.8%, compared with the mortgage portfolio's 8.6% weighted average rate at the end of 2025. The implied gross gap of 2.8 to 4.8 percentage points looks adequate before credit losses, operating costs, unused-line fees and bond funding are included. At low utilization, commitment fees alone can add more than one percentage point to the effective cost of drawn funds. Meanwhile, the controlling owner's C$47 million mortgage transfer increased the subordinated shareholder loan to about C$131 million, but it did not inject cash and was not presented as accounting equity. The facility's economic value will therefore be determined by actual drawings, portfolio growth, the spread after credit losses, CMHC exits and reported headroom under the four new covenants.

The Facility Costs Money Even While It Sits Idle

The facility was signed through a wholly owned and controlled subsidiary with a consortium led by Bank of Montreal. It includes C$250 million for uninsured mortgages and C$100 million for insured mortgages. Swing lines of up to C$20 million sit inside the total, and the agreement allows a further C$50 million increase subject to its conditions. Peakhill can draw, repay and redraw through July 20, 2028.

The 8.6% portfolio rate at the end of 2025 is not a forecast for new production. It also excludes lender fees earned by Peakhill. It nevertheless provides a useful scale for the margin the facility must preserve.

This is an illustration, not a forecast. It excludes credit losses, operating expenses, facility fees and the cost of public debt, and assumes new loans earn a rate similar to the 2025 average. Peakhill separately summarizes its expected funding-cost range as 3.6% to 5.8% in the same filing. Because the difference from the lowest detailed rate is not explained, the table uses the explicitly listed rates of 3.8%, 4.7%, 4.9% and 5.8%.

Expected credit-loss expense was about C$4 million in 2025. Relative to the average gross portfolio balance at the beginning and end of the year, that was about 0.9%. If a similar burden applied to new production, it would reduce the illustrative gross gap to roughly 1.9 to 3.9 percentage points before other operating and financing costs.

Utilization also matters. While less than half of the first line is drawn, Peakhill pays 0.5% on the unused balance. The equivalent fee on the second line is 0.3%. Above 50% utilization, those rates fall to 0.3% and 0.1%, respectively. Assuming proportional drawings from both lines, 25% utilization produces an annual unused fee of about C$1.16 million, equivalent to roughly 1.33% of the drawn amount. At 60% utilization, the fee falls to about C$340,000, or 0.16% of the drawn balance. The new funding source therefore rewards rapid loan deployment, but can dilute earnings if Peakhill reserves substantial capacity without suitable borrowers.

Four Covenants Put Boundaries Around Growth

The banks have not committed to fund every mortgage Peakhill presents. Each draw requires a request, a borrowing-base report, eligible mortgages and the absence of a default. The facility is also based on maximum leverage of 50% of the asset portfolio. The stated potential to support a portfolio of about C$1.1 billion therefore depends on more than the credit limit. It also depends on capital, loan rotation and the availability of eligible assets.

Peakhill says its pro forma calculations indicate compliance in 2026 and 2027, but it did not disclose the calculated ratios. Headroom therefore cannot be measured. This matters because Series A carried a 6.34% annual coupon, while its principal had reached NIS863.451 million by the end of March 2026. The combined coverage test brings that shekel bond-interest layer into the calculation alongside bank interest.

The agreement also restricts additional debt, liens, distributions and related-party transactions and includes cross-default provisions for other material obligations. A continuing default adds two percentage points to the applicable rates. Portfolio growth therefore depends on more than loan demand. EBITDA, tangible capital and asset quality must also grow with the debt.

The Mortgage Transfer Was Not a Cash Injection

Peakhill Capital transferred a mortgage portfolio of about C$47 million to the partnership. Consideration took the form of an increase in the subordinated shareholder loan, bringing it to about C$131 million. The transaction adds mortgage assets and a controlling-owner funding layer, but no new cash.

The distinction from accounting equity matters. The partnership reported about C$363 million of accounting equity at the end of March, while the shareholder loan remains a separate layer. The Series A deed's equity definition adds subordinated shareholder loans to accounting equity, allowing the transfer to support bond covenant measures without converting the loan into ordinary accounting equity. The terms disclosed in July describe the loan as interest-free, unsecured and subordinated to other liabilities. They also state that the controlling owner will not seek and is not entitled to repayment, including in liquidation. Those terms provide bondholders with a real loss-absorbing layer, but it is still not the same as cash or capital accumulated through retained earnings.

The banks sit on the other side of the structure. They received first liens over borrower assets, mortgage rights, insurance policies and receivables. Series A is unsecured and ranks behind secured partnership debt. The earlier capital-stack analysis asked whether bank credit would move inside the partnership. The answer is now clearer: funding enters through a controlled subsidiary with broad collateral and priority over the financed assets. Liquidity improved, but the creditor hierarchy became more complex.

The Next Reports Must Show Use, Margin and Credit Quality

Four disclosures will determine whether the facility expands earning power. The first is the drawn balance and the mortgage portfolio created with it. The second is the difference between interest income and bank costs, facility fees and credit losses. The third is migration in Stage 2 and Stage 3 and the pace at which bridge loans exit into permanent CMHC funding. The fourth is the actual ratio under each covenant, including clarification of whether and how the shareholder loan enters the facility's tangible-net-worth calculation.

A signed facility is stronger than a financing plan that remains under negotiation, and it can materially expand earning assets. It does not yet prove that growth will add earnings or cash. Low utilization raises the effective cost of funds, rapid utilization increases credit exposure, and the collateral package places the banks ahead of bondholders. The positive reading will be confirmed only when drawings become loans that retain a margin after provisions, without accumulation in Stage 3 or erosion of covenant headroom.